We first analyzed IL-1β expression in an ovarian cancer TMA consisting of eight normal ovarian tissue samples, 47 high-grade serous carcinoma samples, and 14 internal carcinoma samples. This evidence concerns the gene IL1B and ovarian carcinoma.